ClearPoint Neuro Q3 2024 Earnings Report $12.14 -0.95 (-7.26%) As of 04/3/2025 04:00 PM Eastern Earnings HistoryForecast ClearPoint Neuro EPS ResultsActual EPS-$0.18Consensus EPS -$0.17Beat/MissMissed by -$0.01One Year Ago EPS-$0.20ClearPoint Neuro Revenue ResultsActual Revenue$8.12 millionExpected Revenue$8.07 millionBeat/MissBeat by +$50.00 thousandYoY Revenue GrowthN/AClearPoint Neuro Announcement DetailsQuarterQ3 2024Date11/7/2024TimeAfter Market ClosesConference Call ResourcesConference CallSlide DeckPress ReleaseCLPT Earnings HistoryConference Call AudioYour browser does not support the audio element. Listen Now.Slide DeckFull Screen Slide DeckPowered by Remove Ads ClearPoint Neuro Earnings HeadlinesClearPoint Neuro (NASDAQ:CLPT) Price Target Raised to $25.00April 2 at 3:17 AM | americanbankingnews.comHere's Why We're Not Too Worried About ClearPoint Neuro's (NASDAQ:CLPT) Cash Burn SituationMarch 30, 2025 | finance.yahoo.comBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical technology that could change society forever and make early investors rich.April 4, 2025 | Stansberry Research (Ad)ClearPoint Neuro (CLPT) Receives a Buy from Stifel NicolausMarch 4, 2025 | markets.businessinsider.comClearPoint Neuro: Drug Delivery Prospects Continue To StrengthenFebruary 28, 2025 | seekingalpha.comClearPoint Neuro reports Q4 revenue $7.8M, consensus $8.23MFebruary 26, 2025 | markets.businessinsider.comSee More ClearPoint Neuro Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like ClearPoint Neuro? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ClearPoint Neuro and other key companies, straight to your email. Email Address About ClearPoint NeuroClearPoint Neuro (NASDAQ:CLPT) operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.View ClearPoint Neuro ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Lamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go Higher Upcoming Earnings Bank of New York Mellon (4/11/2025)BlackRock (4/11/2025)JPMorgan Chase & Co. (4/11/2025)Progressive (4/11/2025)Wells Fargo & Company (4/11/2025)Interactive Brokers Group (4/15/2025)Bank of America (4/15/2025)Citigroup (4/15/2025)Johnson & Johnson (4/15/2025)Morgan Stanley (4/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
